Skip to main content

Small Intestinal NET clinical trials at UC Irvine

1 in progress, 0 open to eligible people

Showing trials for
  • Open-Label Surufatinib in European Patients With NET

    Sorry, not currently recruiting here

    This is a Phase 2, open-label, multi-centre study of surufatinib in patients with low to intermediate grade (Grade 1 or Grade 2), well-differentiated neuroendocrine tumours (NETs).

    Orange, California and other locations

Last updated: